Raymond James Initiates Coverage on Accelerant with Outperform Rating
Raymond James starts coverage on Accelerant with an Outperform rating and $33 price target, highlighting positive market outlook and financial prospects in the insurance sector.
Raymond James starts coverage on Accelerant with an Outperform rating and $33 price target, highlighting positive market outlook and financial prospects in the insurance sector.
F&G Annuities & Life reports missed Q1 2025 earnings and downward revisions to full-year revenue and earnings forecasts amid market uncertainties.
S&P Global Ratings considers downgrading Centene's credit rating to junk after the insurer withdraws its 2025 earnings forecast, citing uncertainty in Affordable Care Act plans and market trends impacting capital build.
The Progressive Corporation's earnings outlook improves with rising investment income and lower expense ratios, set against a backdrop of increasing AI-driven energy infrastructure demand shaping U.S. insurance market trends.
First Street's assessment shows climate disasters in the US driving up mortgage foreclosures through rising insurance costs, flood damage, and credit risk, threatening housing market stability.
Travelers Companies set to announce Q1 2025 earnings; stock rises despite expected profit decline.
A recent study reveals the increasing disparity between rising healthcare profits and patient struggles with costs, raising questions about investment priorities in the health sector.